Reference
Hempel L, et al. Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib: A case report. Memo - Magazine of European Medical Oncology 14: 386-391, No. 4, Dec 2021. Available from: URL: http://www.springer.com/springerwiennewyork/medicine/journal/12254
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1889, 48 (2022). https://doi.org/10.1007/s40278-022-08727-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08727-3